Literature DB >> 33396692

Trends in Participation Rates of the National Cancer Screening Program among Cancer Survivors in Korea.

E Hwa Yun1,2, Seri Hong1, Eun Young Her1, Bomi Park1, Mina Suh1,2, Kui Son Choi1,2, Jae Kwan Jun1,2.   

Abstract

The study aimed to describe the participation rates of the National Cancer Screening Program (NCSP) among cancer survivors in Korea. The NCSP protocol recommends that all Korean men and women should be screened for cancer. Cancer survivors were defined as those registered for any cancer in the Korea Central Cancer Registry by December 31 of the year prior to being included in the target population of the NCSP. In this study, the participation rates for the NCSP were calculated as the percentage of people who participated in four kinds of cancer screening programs, independently. The average annual percentage change was assessed. The participation rates of the general population and cancer survivors were higher than 40% in stomach, breast, and cervical cancer screening. These rates were higher than that of colorectal cancer screening in 2014. In addition, the participation rates in the NCSP in 2002-2014 increased for all cancer types. The NCSP participation rates of the cancer survivors indicate the high demand for cancer screening. Further research may investigate the effect of the NCSP on second cancer occurrence or mortality in cancer survivors and the significance of cancer screening guidelines for cancer survivors.

Entities:  

Keywords:  cancer; cancer screening; cancer survivor

Year:  2020        PMID: 33396692     DOI: 10.3390/cancers13010081

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  4 in total

Review 1.  Machine learning in neuroimaging: from research to clinical practice.

Authors:  Karl-Heinz Nenning; Georg Langs
Journal:  Radiologie (Heidelb)       Date:  2022-08-31

2.  Cost Utility Analysis of a Pilot Study for the Korean Lung Cancer Screening Project.

Authors:  Juyoung Kim; Bogeum Cho; Seon-Ha Kim; Chang-Min Choi; Yeol Kim; Min-Woo Jo
Journal:  Cancer Res Treat       Date:  2021-09-24       Impact factor: 5.036

3.  Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment.

Authors:  Hayoung Lee; Young Hoon Kim; Seong Jun Lim; Youngmin Ko; Sung Shin; Joo Hee Jung; Chung Hee Baek; Hyosang Kim; Su-Kil Park; Hyunwook Kwon
Journal:  Ann Surg Treat Res       Date:  2022-01-03       Impact factor: 1.859

4.  Health behavior changes and mortality among South Korean cancer survivors.

Authors:  Wonjeong Jeong; Eun-Cheol Park; Chung Mo Nam; Sohee Park; Jin Young Nam; Sung-In Jang
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.